Contact
      Please use this form to send email to PR contact of this press release:
      
      InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery in a Breakthrough Study
    
      TO:
      
      Rositsa Hadzhipetrova
      
      InSphero AG
      
      +41 44 515 04 90